Summary: Lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPOEIAS in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.
Publications226 found, 100 shown here
- Spillover effects of restrictive drug formularies: a case study of PacifiCare in CaliforniaY Richard Wang
Public Policy Department, AstraZeneca Pharmaceuticals, Wilmington, Del 19850 5437, USA
Am J Manag Care 11:24-6. 2005..A restrictive drug formulary may influence how physicians treat other, unaffiliated patients, a phenomenon known as the "spillover effect." In a previous study we found significant spillover effects from Maine's Medicaid formulary...
- Identifying widely covered drugs and drug coverage variation among Medicare part D formulariesChien Wen Tseng
Department of Family Medicine and Community Health, John A Burns School of Medicine at University of Hawaii, Honolulu, USA
JAMA 297:2596-602. 2007Clinicians can find it difficult to know which drugs are covered for their Medicare patients because formularies vary widely among Medicare Part D plans and many states have 50 or more such plans.
- Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary)Neda Tavassoli
Clinical Pharmacology Department, Centre of Pharmacoepidemiology and Drug Information, Pharmacoepidemiology Unit, Faculty of Medicine, Paul Sabateir University, Toulouse, France
Drug Saf 30:1063-71. 2007..Cholinesterase inhibitors (ChEIs) could be involved in several drug-drug interactions (DDIs) because of their complex pharmacodynamic and/or pharmacokinetic properties...
- Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to MedicaidMatthew M Murawski
Department of Pharmacy Practice, Purdue University School of Pharmacy and Pharmacal Sciences, West Lafayette, IN 47907 2051, USA
Am J Manag Care 11:SP35-42. 2005....
- Effects of restrictive formularies in the ambulatory care settingJoel Lexchin
School of Health Policy and Management, York University, Toronto, Canada
Am J Manag Care 8:69-76. 2002To determine the consequences of restrictive formularies in the ambulatory care setting in 4 areas: overall drug expenditures, overall healthcare spending, changes in the quality of prescribing, and health outcomes.
- The effect of incentive-based formularies on prescription-drug utilization and spendingHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 349:2224-32. 2003Many employers and health plans have adopted incentive-based formularies in an attempt to control prescription-drug costs.
- Physicians' views of formularies: implications for Medicare drug benefit designBruce E Landon
Harvard Medical School, Beth Israel Deaconess Medical Center, USA
Health Aff (Millwood) 23:218-26. 2004..Physicians Survey, a large, nationally representative study of physicians, to learn about physicians' views of formularies. Our results suggest that several aspects of formularies are associated with physicians' positive views about ..
- Incentive formularies and changes in prescription drug spendingBruce E Landon
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
Am J Manag Care 13:360-9. 2007To examine the impact of incentive formularies on prescription drug spending shifts in formulary compliance, use of generic medications, and mail-order fulfillment in the year after introduction of a new pharmacy benefit strategy.
- The new medicare drug benefit: formularies and their potential effects on access to medicationsHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, Boston, Mass, USA
J Gen Intern Med 20:662-5. 2005..Relatively little attention was paid to details about how plans would operate, such as the design of drug formularies. Yet, formularies will be important tools for controlling costs, and may be as important as nominal benefit ..
- Consumer knowledge and perceptions of formulariesSujit S Sansgiry
University of Houston, College of Pharmacy, Houston, Texas 77030, USA
Manag Care Interface 17:21-6, 30. 2004A study was undertaken to determine consumer knowledge and perceptions of formularies. A prevalidated survey containing 11 scored items was administered to 714 consumers waiting to receive prescription medications at 72 community ..
- Consumer response to dual incentives under multitiered prescription drug formulariesBoyd H Gilman
Mathematica Policy Research, Inc, Cambridge, MA 02139, USA
Am J Manag Care 13:353-9. 2007To decompose the overall effect of multitiered formularies on drug utilization and spending into the following 2 observed effects on consumer behavior: first, higher copayments on drug equivalents create an incentive to reduce the number ..
- Designing pediatric vaccine formularies and pricing pediatric combination vaccines using operations research models and algorithmsSheldon H Jacobson
Department of Mechanical and Industrial Engineering, University of Illinois, Urbana, USA
Expert Rev Vaccines 2:15-9. 2003....
- Access to drug therapy and substitution between alternative antidepressants following an expansion of the California Medicaid formularyJeffrey S McCombs
Department of Pharmaceutical Economics and Policy, USC School of Pharmacy, University of Southern California, 1540 E Alcazar St, Rm CHP 140, Los Angeles, CA 90033, USA
Health Policy 65:301-11. 2003..However, while some expansion in overall antidepressant use may have been desired, the clinical validity of this expansion cannot be determined based on the results presented here...
- Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in childrenHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
Arch Gen Psychiatry 62:435-41. 2005..Many employers and health plans have adopted 3-tier formularies in an attempt to control costs for these and other drugs.
- How effectively do managed care organizations influence prescribing and dispensing decisions?Norman V Carroll
School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA
Am J Manag Care 8:1041-54. 2002To examine the extent to which managed care organizations (MCOs) use formularies, therapeutic interchange, and prior approval and to determine how effectively these tools influence prescribing and dispensing decisions.
- Physicians' prescribing responses to a restricted formulary: the impact of Medicaid preferred drug lists in Illinois and LouisianaSuchin Virabhak
Department of Economics, Columbia University, New York, NY, USA
Am J Manag Care 11:SP14-20. 2005..To determine the extent to which the strictness of the criteria used to control utilization of drugs not on a Medicaid preferred drug list (PDL) changes physician prescribing habits for non-Medicaid patients...
- The effect of access restrictions on the vintage of drugs used by Medicaid enrolleesFrank R Lichtenberg
Graduate School of Business, Columbia University, New York, NY 10027, USA
Am J Manag Care 11:SP7-13. 2005..To examine the extent to which recent Medicaid drug access restrictions, such as preferred drug lists (PDLs), may affect the vintage (or time since Food and Drug Administration approval) of 6 types of drugs used by Medicaid beneficiaries...
- Angiotensin receptor blockers on the formularies of Medicare drug plansWalid F Gellad
Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 1620 Tremont Street, Boston, MA 02120 1613, USA
J Gen Intern Med 22:1172-5. 2007The presence of angiotensin receptor blockers (ARBs) on the formularies of Medicare Part D prescription drug plans (PDPs) is vitally important to the health of seniors who cannot tolerate angiotensin-converting enzyme (ACE) inhibitors.
- How do incentive-based formularies influence drug selection and spending for hypertension?Sachin Kamal-Bahl
Pharmaceutical Health Services Research Program, School of Pharmacy, University of Maryland Baltimore, USA
Health Aff (Millwood) 23:227-36. 2004This study examined the association between incentive-based formularies and antihypertensive drug selection and spending. We compared the use of drugs from five drug classes by the number of tiers and copayment differentials...
- States' control of prescription drug spending: a heterogeneous approachNancy E Morden
University of Washington, in Seattle, USA
Health Aff (Millwood) 24:1032-8. 2005....
- Formularies, therapeutics, and outcomes: new opportunitiesD S Pete Fullerton
Pharmaceutical Outcomes Research and Policy Program, College of Pharmacy, University of Washington, Seattle, Washington 98105, USA
Med Care 42:III39-44. 2004..patient compliance and health outcomes after implementation of a Medicare prescription drug benefit, and the need for new types of clinical trials that can respond to changing demands of pharmacy and therapeutics committees and providers..
- Incentives and pharmaceutical reimbursement reforms in SpainJaume Puig-Junoy
Research Centre for Health and Economics CRES, Department of Economics and Business, Pompeu Fabra University, C Trias Fargas 25 27, 34 08005 Barcelona, Spain
Health Policy 67:149-65. 2004..In the final section of this paper, we present an overall assessment of the impact of these pharmaceutical reimbursement policies on the behaviour of the agents in the pharmaceutical market...
- Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitorsY Richard Wang
Health Services Research and Policy Analysis, Public Policy Department, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850 5437, USA
Manag Care Interface 18:39-45. 2005..They found that although drug formulary restrictiveness increases the use of preferred products, it also leads to a high level of formulary noncompliance. The net financial effect on drug spending is ambiguous...
- Evaluating the nondrug costs of formulary coverage restrictionsPaul Abourjaily
Tufts New England Medical Center, 750 Washington St Boston, MA 02111, USA
Manag Care 14:50-7, 62. 2005..To explore the effect of these initiatives, we sought clinicians' feedback regarding their practices and processes for switching patients' medications to accommodate insurance coverage...
- The effect of generic competition on the price of brand-name drugsJoel Lexchin
Emergency Department, University Health Network, Toronto, Ont, Canada
Health Policy 68:47-54. 2004..Literature from the US has shown that brand-name manufacturers do not compete on price once generic competitors become available. This study was undertaken to investigate if this is also true in Canada...
- Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilizationPamela B Landsman
Outcomes Research and Management, US Medical and Scientific Affairs, Merck and Company Inc, PO Box 100, UG2B 74, 351 N Sumneytown Pike, North Wales, PA 19454 2505, USA
Am J Manag Care 11:621-8. 2005..To estimate responsiveness of prescription demand within 9 therapeutic classes to increased cost-sharing compared with constant cost-sharing...
- Prescription drug benefits under Part D of the Medicare Modernization Act--the genie's out of the bottleL Sue Andersen
Health Benefits ABCs
Issue Brief Cent Medicare Educ 5:1-10. 2005..In this brief, we discuss the new Part D benefit, including who is eligible, the basic benefit, benefits for low-income individuals and coordination with other prescription drug coverage...
- The subsidy of pharmaceuticals in Australia: processes and challengesLloyd Sansom
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide 5000, South Australia
Aust Health Rev 28:194-205. 2004..The relevant issues are discussed in this article to assist that debate...
- Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims dataS Michael Ross
Advanced Concepts Institute, 600 South 43rd Street, Philadelphia, PA 19104, USA
J Manag Care Pharm 11:410-5. 2005..Electronic prescribing (e-prescribing) provides formulary information at the point of care. The objective of this study was to assess the effects of e-prescribing on formulary compliance and generic utilization...
- Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic diseaseKavita V Nair
University of Colorado Health Sciences Center, School of Pharmacy, 4200 East Ninth Ave, Box C 238, Denver, CO 80262, USA
J Manag Care Pharm 9:123-33. 2003..To evaluate the impact of 3-tier (copayment) pharmacy benefit structures on medication utilization behavior...
- Budget impact of tegaserod on a managed care organization formularyMichael A Bloom
Innovative Health Solutions, Brookline, Massachusetts, USA
Am J Manag Care 11:S27-34. 2005..When the associated budget impact of adding tegaserod to its formulary is absorbed across an entire MCO population, the PMPM impact of tegaserod is small...
- Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugsBecky Briesacher
Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester 01605, USA
Arch Intern Med 164:1679-84. 2004Previous studies of 3-tier formularies are rare, although the evidence suggests that their cost-sharing structure reduces overall drug spending...
- Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitorsMichael A Fischer
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
N Engl J Med 351:2187-94. 2004..To control these expenses, many state Medicaid programs have implemented prior-authorization requirements before coxibs can be prescribed. We evaluated the effect of such programs on the use of coxibs by Medicaid beneficiaries...
- Medicare Part D: an overview of its practical and clinical impactSteve Usdin
BioCentury Publications, Washington, DC 20009, USA
Am J Geriatr Cardiol 14:284-8; quiz 289-90. 2005..have to help their patients navigate the new benefit as well as adjust their practices to deal with multiple formularies with different coverage policies...
- Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costsKathleen A Fairman
Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
Clin Ther 25:3147-61; discussion 3144-6. 2003..Assessment of such systems with a longer follow-up period has been needed...
- Approaches to pharmacy benefit management and the impact of consumer cost sharingBridget M Olson
The University of Arizona, College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, Tucson, Arizona 85721 0207, USA
Clin Ther 25:250-72. 2003..An understanding of the most prominent mechanisms of benefit management is an important step in determining the most effective approach to take in future years...
- Do consumers' attitudes predict prescription purchasing behavior?Kavita V Nair
School of Pharmacy, University of Colorado Health Sciences Center, Denver, USA
Manag Care Interface 16:22-7, 55. 2003..The findings appear to support the concept of three-tier plans, and increasing copayments seems to facilitate greater adherence to health plan formularies.
- Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision makingC Daniel Mullins
School of Pharmacy, Center on Drugs and Public Policy, University of Maryland, Baltimore, Maryland, USA
Pharmacoeconomics 20:9-21. 2002..Direct comparator studies are starting to emerge, but in limited numbers. The need for additional training of pharmaceutical representatives and PBM staff members remains a critical issue...
- Comparing patient access to pharmaceuticals in the UK and USJoshua Cohen
Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Appl Health Econ Health Policy 5:177-87. 2006..Additional barriers have since been identified. These pertain to reimbursement and pricing of approved drugs, the so-called fourth and fifth hurdles...
- Overview of Medicare Part D prescription drug benefit: potential implications for patients with psychotic disordersJack M Rosenberg
International Drug Information Center, Brooklyn, NY 11201, USA
Am J Health Syst Pharm 64:S18-23; quiz S24-5. 2007..Medicare Part D prescription drug benefits are reviewed. Potential implications for patients with psychotic disorders in relation to Medicare Part D are discussed...
- Per-patient-per-month drug costs in Medicare Part D protected classesLisa Mucha
Thomson Medstat, Cambridge, MA 02140, USA
Pharmacoeconomics 24:79-84. 2006....
- Patient access to pharmaceuticals: an international comparisonJoshua Cohen
Tufts Center for the Study of Drug Development, Boston, MA 02111, USA
Eur J Health Econ 8:253-66. 2007..At the same time, our study confirms, qualitatively, different kinds of access problems in the US: relatively high patient cost sharing for pharmaceuticals, and wide variation in coverage...
- Management of access to branded psychotropic medications in private health plansDominic Hodgkin
Institute for Behavioral Health, Schneider Institutes, Heller School of Social Policy and Management, Brandeis University, Waltham, Massachusetts 02454 9110, USA
Clin Ther 29:371-80. 2007..health insurers have increased their reliance on cost control policies such as prior authorization and 3-tier formularies. Little is known about how these policies are being applied to psychotropic medications, many of which have low ..
- Availability of addiction medications in private health plansConstance M Horgan
Institute for Behavioral Health, Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA 02454, USA
J Subst Abuse Treat 34:147-56. 2008..Thirty-one percent of insurance products excluded buprenorphine from formularies, whereas 55% placed it on the highest cost-sharing tier...
- Physician dispensing: an old idea is new againJ Scott Nystrom
Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI, USA
MGMA Connex 6:36-41, 1. 2006..With physician-dispensing prescription costs 50 percent below the national average and generic substitution 50 percent higher than the national average, the potential cost savings for payers and consumers is staggering...
- Shifting the focus from cost to value: a government perspectiveBabette S Edgar
Gorman Health Group, LLC, 2176 Wisconsin Ave, NW, Washington, DC 20007, USA
J Manag Care Pharm 12:S11-5; quiz S24-6. 2006..To examine the federal government.s current health care initiatives in the Centers for Medicare and Medicaid Services (CMS) to improve quality of care and cost-effectiveness around the prescription drug benefit...
- Prior authorization of newer insomnia medications in managed care: is it cost saving?Rajesh Balkrishnan
College of Pharmacy, Ohio State University, Columbus, OH 43210, USA
J Clin Sleep Med 3:393-8. 2007....
- Perverse incentives in the Medicare prescription drug benefitDavid McAdams
Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
Inquiry 44:157-66. 2007..In particular, if all plans were required to charge the same premium, there would be less diversity in quality, but also less need to regulate formulary composition, less budgetary uncertainty, and less upward pressure on drug prices...
- Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventionsSanjoy Roy
Department of Pharmaceutical Systems and Policy, West Virginia University, Morgantown, WV 26505, USA
Pharmacoeconomics 26:281-96. 2008....
- Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006Jennifer Bowman
Avalere Health LLC in Washington, DC, USA
Health Aff (Millwood) 25:1240-8. 2006..Individual Part D plans have discretion to determine their formularies and cost sharing for drugs within federal guidelines...
- Ethical principles for psychiatric administrators: the challenge of formulariesH Steven Moffic
Psychiatry and Family and Community Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
Psychiatr Q 77:319-27. 2006..One such product could be medication algorithms that also incorporate costs, side effects, and general healthcare...
- Reframing the pharmaceutical manufacturer/health plan relationship in managed careIra Studin
Stellar Managed Care, Cherry Hill, NJ 08003, USA
Manag Care 11:46, 49-54. 2002....
- Clinical pharmacology of the appeals and exception process: the interface of the patient, physician, and insurance company to assure appropriate care under Medicare Part DRichard S Blum
St Francis Hospital, Roslyn, NY, USA
J Clin Pharmacol 46:394-7. 2006..Drug formularies, including those available to enrollees in Medicare Part D, are based on group characteristics and financial ..
- The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditionsWilliam H Shrank
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass, USA
Arch Intern Med 166:332-7. 2006..We studied whether patients enrolled in such plans who receive generic or preferred brand-name agents when initiating chronic therapy were more adherent to treatment than those who received nonpreferred brand-name medications...
- Do drug formulary policies reflect evidence of value?Peter J Neumann
Department of Health Policy and Management and Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
Am J Manag Care 12:30-6. 2006To investigate the extent to which preferred drug lists and tiered formularies reflect evidence of value, as measured in published cost-utility analyses (CUAs).
- Implications of Part D for mentally ill dual eligibles: a challenge for MedicareNancy E Morden
Department of Family Medicine, University of Washington School of Medicine, Seattle, USA
Health Aff (Millwood) 25:491-500. 2006..We discuss the details and policy implications of this challenge...
- United States pharmacopeia development of the Medicare model formulary guidelinesLeonard Bielory
University of Medicine and Dentistry of New Jersey UMDNJ New Jersey Medical School, Newark, NJ 07081, USA
Am J Geriatr Cardiol 14:301-7. 2005Prescription drug formularies are a key element in prescription drug benefit management. The use of formularies can both increase the quality of prescribing and reduce the costs of prescription drug therapy...
- A first look at the new Medicare prescription drug plansAustin B Frakt
Veterans Affairs Boston Healthcare System in Boston, Massachusetts, USA
Health Aff (Millwood) 25:W252-61. 2006..One national stand-alone drug plan, though, covers brand-name drugs with no gap. Variations in cost sharing and formularies provide beneficiaries with choices as well as complexity.
- The economic burden associated with prior authorizations in an allergist officeDon A Bukstein
Department of Allergy, Dean Medical Center, Madison, Wisconsin 53715, USA
Allergy Asthma Proc 27:119-22. 2006..Specialty physicians should have a different process for obtaining notformulary medications because almost 100% of their requests are granted...
- Prediction of Medicare drug formulary drugs for treatment of overactive bladderJoseph A Grocela
Department of Urology, Massachusetts General Hospital, Bigelow 1102, Boston, MA 02114, USA
J Urol 176:252-5; discussion 255-6. 2006..Establishment of the Medicare Part D drug formulary will allow cost containment but still absorb patient and physician preferences as well as a consideration of efficacy and safety data...
- Preparing residents for managed care practice using an experience-based curriculumA G Gomez
UCLA School of Medicine, Sepulveda Veterans Health Administration Medical Center, CA 91343, USA
Acad Med 72:959-65. 1997..where they will be expected to arrive skilled in managed care activities such as prescribing with formularies and adhering to preauthorization processes for procedures, referrals, and hospital admissions...
- Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementiaFrank J Molnar
Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
J Am Geriatr Soc 57:536-46. 2009..detect clinically important difference) and for decisions regarding whether medications should be accepted on formularies and should be funded...
- Utilization of restricted antibiotics in a university hospital in ThailandSasima Kusuma Na Ayuthya
Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 34:179-86. 2003..used to control antibiotic usage including the use of an antibiotic order form (AOF), restricted antibiotic formularies and provision of educational information...
- Teaching the basics of clinical pharmaceutical care: innovative pharmacy workshops at the University of Wisconsin and the University of NebraskaDean R Keller
Department of Internal Medicine, University of Wisconsin, WI 53706, USA
Fam Med 36:S89-92. 2004Safe and effective prescription writing, using drug formularies, and managing pharmaceutical care are skills medical students need to acquire...
- Use of antipsychotic medications in treating schizophrenia among different financing and delivery systemsJoan R Bloom
School of Public Health, Uuniversity of California, Berkeley, CA 94720 7360, USA
J Ment Health Policy Econ 6:163-71. 2003..Pharmaceuticals were not included in the capitation rate. However, antipsychotic medications were included in the formularies for consumers who received their medical care through a Health Maintenance Organization (HMO).
- Prescribing and dispensing activities at the health facilities of a non-governmental organizationA Hazra
Community Development Medicinal, Unit Documentation Centre, Calcutta, West Bengal, India
Natl Med J India 13:177-82. 2000..Prescribing and dispensing surveys are pre-requisites to achieving rational drug use. There is a dearth of such studies in India, particularly in the non-governmental organization sector...
- Hospital policies for treatment of acute decompensated heart failureVikrant Vats
Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA
Ann Pharmacother 41:562-7. 2007..It is unclear to what extent hospitals use guidelines or protocols in treating acute decompensated heart failure (ADHF) and whether nesiritide is included in these guidelines or protocols...
- Information resource preferences by general pediatricians in office settings: a qualitative studyGeorge R Kim
Division of Health Sciences Informatics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
BMC Med Inform Decis Mak 5:34. 2005..Information needs and resource preferences of office-based general pediatricians have not been well characterized...
- Toward a standard drug formulary for the treatment of headacheJ A Klapper
Colorado Neurology and Headache Center, Denver, USA
Headache 35:225-7. 1995The recent publication of drug formularies by third-party payers has serious implications for the practice of medicine. These formularies list the medications for which the consumer can be reimbursed by the third-party payer...
- Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISHBarry L Carter
Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, 511 South Grand, Iowa City, IA 52240, USA
J Manag Care Pharm 10:S18-25. 2004..The strategies for lowering BP levels include patient lifestyle changes, adherence to therapy, and regular monitoring of BP levels...
- Are incentive-based formularies inversely associated with drug utilization in managed care?Patrick P Gleason
Prime Therapeutics, LLC, Eagan, MN 55121 3497, USA
Ann Pharmacother 39:339-45. 2005To review recent studies comprehensively assessing the impact of incentive-based multitier formularies on pharmaceutical costs and utilization.
- [Prescribing and dispensing generic drugs in the Mambéré-Kadéï health district of the Central African Republic]C Mouala
Faculté des Sciences de la Santé BP 1383 Bangui, RCA
Med Trop (Mars) 68:149-54. 2008..dispensed drugs, and lack of access to standard drug use tools such as a locally adapted essential drug list, formularies and standard treatment guidelines...
- Clinical outcome of a mandatory formulary switch for dihydropyridine calcium channel blocker therapy at a Veteran's Administration Medical CenterG Gustin
Section of Hypertension and Vascular Diseases, University of Connecticut School of Medicine, Farmington, USA
Am J Hypertens 9:312-6. 1996..antihypertensive therapies with similar properties have been made based primarily on cost savings for hospital formularies. To assess blood pressure (BP) control and adverse side effects associated with a switch of patients on ..
- Teaching of medical informatics in UME-21 medical schools: best practices and useful resourcesCraig L Gjerde
Department of Family Medicine, University of Wisconsin 53706, USA
Fam Med 36:S68-73. 2004....
- Engineering the economic value of two pediatric combination vaccinesSheldon H Jacobson
Department of Mechanical and Industrial Engineering, University of Illinois, Urbana, IL 61801, USA
Health Care Manag Sci 8:29-40. 2005..of the paper is to provide a methodology for analyzing the impact of combination vaccines on pediatric vaccine formularies. This analysis shows that the DTPa-HBV-IPV vaccine may provide a good value at the current federally negotiated ..
- Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugsWilliam H Shrank
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
Ann Pharmacother 40:1534-40. 2006Most insurers in the US have implemented incentive-based formularies that rely on out-of-pocket costs to influence prescription drug utilization. Medicare Part D plans have broadly adopted such benefit designs.
- Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative studyLi Chia Chen
School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, 1st Floor, Stopford Building, Oxford Road, Manchester, M13 9PT, UK
Pharm World Sci 29:661-70. 2007....
- Medicine reimbursement recommendations in Canada, Australia, and ScotlandJoel Lexchin
School of Health Policy and Management, York University, 4700 Keele St, Toronto, Ontario, Canada M3J 1P3
Am J Manag Care 14:581-8. 2008..was undertaken to compare the recommendations made by the Canadian Common Drug Review (CDR) regarding whether drugs should be listed on provincial and federal formularies with recommendations made by similar bodies in other countries.
- Infection control programs at children's hospitals: a description of structures and processesS Girouard
National Association of Children s Hospitals and Related Institutions, Alexandria, VA 22314, USA
Am J Infect Control 29:145-51. 2001..Components of antimicrobial restriction programs included infectious disease specialist approval, restricted formularies, selective susceptibility test reporting, and staff education programs...
- ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004Craig A Pedersen
Division of Pharmacy Practice and Administration, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210 1291, USA
Am J Health Syst Pharm 62:378-90. 2005..Results of the 2004 ASHP national survey of pharmacy practice in hospital settings that pertain to prescribing and transcribing are presented...
- The impact of hurricanes and flooding disasters on hymenopterid-inflicted injuriesJames H Diaz
Environmental and Occupational Health Sciences, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
Am J Disaster Med 2:257-69. 2007..to alert regional healthcare providers of the increased risks of hymenopterid-inflicted injuries following flooding disasters and to assure that emergency drug formularies are properly stocked to treat hymenopterid-inflicted injuries.
- Chronic kidney disease and medicareWendy L St Peter
College of Pharmacy at the University of Minnesota, Minneapolis, MN 55404, USA
J Manag Care Pharm 13:S13-8. 2007..The ESRD population faces significant hurdles when using the new Part D benefit. To understand those challenges, a basic understanding of Part D is needed...
- Cost comparison of beta 2-agonist bronchodilators used in the treatment of asthmaC H Nightingale
School of Pharmacy, University of Connecticut, Storrs, USA
Pharmacotherapy 15:677-81. 1995..In addition, agents that can be dosed as needed (i.e., albuterol) are likely to be more cost-effective choices for formularies than more expensive new bronchodilators such as salmeterol, which must be given twice/day on a regular basis.
- A manifesto for clinical pharmacology from principles to practiceJeffrey K Aronson
University Department of Primary Health Care, Rosemary Rue Building, Old Road Campus, Headington, Oxford OX3 7LF, UK
Br J Clin Pharmacol 70:3-13. 2010..and general practice; policy makers, framing local, national, and international medicines policy, including formularies, licensing of medicines and prescribing policies. 5...
- Impact of hospital formularies on fluoroquinolone prescribing in emergency departmentsSherrie L Aspinall
Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, and Unviersity of Pittsburgh School of Pharmacy, Pittsburgh, PA 15240, USA
Am J Manag Care 13:241-8. 2007..To examine factors associated with fluoroquinolone prescribing among adults receiving antibiotics for acute respiratory tract infections (ARIs) in emergency departments...
- Pharmaceutical cost containment and innovation in the United StatesN M Kane
Harvard School of Public Health, Boston, MA 02215, USA
Health Policy 41:S71-89. 1997..There are no price controls, no national drug formularies, no universal cost-sharing policies, and perhaps most important, no national coverage of prescription drugs...
- Doctorline: a private toll-free telephone medical information service. Five years of activity: old problems and new perspectivesA Nobili
Laboratorio di Neuropsichiatria Geriatrica, Istituto di Ricerche Farmacologiche, Mario Negri, Milan, Italy
Ann Pharmacother 32:120-5. 1998..In some cases it can be difficult to gain access to the different sources of medical information. In an attempt to overcome these problems, a toll-free telephone medical information service (Doctorline) was established...
- Survey of hospitals for guidelines, policies, and protocols for anticoagulantsVikrant Vats
Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
Am J Health Syst Pharm 64:1203-8. 2007....
- 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North CarolinaSohini Sengupta
Department of Social Medicine, University of North Carolina at Chapel Hill, MacNider Hall, CB 7240, Chapel Hill, NC 27599 7240, USA
N C Med J 69:6-13. 2008..This analysis examines Medicare Part D antiretroviral coverage in 2007 for beneficiaries with HIV/AIDS in North Carolina, particularly those who did not qualify as dual eligibles or for a full low-income subsidy...
- An informatics approach to assess pediatric pharmacotherapy: design and implementation of a hospital drug utilization systemAthena Zuppa
Clinical Pharmacology and Therapeutics, Abramson Research Center, Suite 916 J, The Children s Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104, USA
J Clin Pharmacol 47:1172-80. 2007..can provide a mechanism to assess drug prescribing trends, efficiency, and cost-effectiveness of hospital formularies and examine subpopulations for which prescribing habits may be different...
- Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005Mary Jean Brown
Lead Poisoning Prevention Branch, Division of Emergency and Environmental Health Services, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Pediatrics 118:e534-6. 2006..providers who are unfamiliar with chelation consult an expert before undertaking treatment and that hospital formularies evaluate whether stocking edetate disodium is necessary, given the risk for hypocalcemia and the availability ..
- Health information technology and physicians' knowledge of drug costsChien Wen Tseng
Department of Family Medicine and Community Health, University of Hawaii, Honolulu, 96789, USA
Am J Manag Care 16:e105-10. 2010..To examine whether physicians' use of information technology (IT) was associated with better knowledge of drug costs...
- Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budgetGregory S Zaric
Richard Ivey School of Business, University of Western Ontario, Canada
Health Econ 14:793-803. 2005Many public and private healthcare payers use formularies as a tool for controlling drug costs and quality...
- Pharmacists' perceptions of the effectiveness of antimicrobial control programsGail S Itokazu
College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA
Am J Health Syst Pharm 63:2504-8. 2006..The perceptions of the effectiveness of antimicrobial control programs (ACPs) among infectious diseases (ID) pharmacists were studied...
- Misleading score-lines on tablets: facilitated intake or fractional dosing?Isabelle Arnet
Pharmaceutical Care Research Group, Pharmazentrum, Basel, Switzerland
Swiss Med Wkly 140:105-10. 2010..information is expected to be in the Summary of Product Characteristics (SPCs), the package leaflets (PLs) or Hospital Drug Formularies. We investigated the accuracy of splitting statements in these three sources of drug information.
- A web-based tool for designing vaccine formularies for childhood immunization in the United StatesSheldon H Jacobson
Department of Computer Science, Simulation and Optimization Laboratory, University of Illinois, Urbana, IL 61801, USA
J Am Med Inform Assoc 15:611-9. 2008..A description of the tool's capabilities is provided. RESULTS on the use of the software tool are reported and discussed...
- Implications of CATIE for mental health services researchersNancy H Covell
Department of Psychiatry, Mt Sinai School of Medicine, New York, NY, USA
Psychiatr Serv 59:526-9. 2008..Given the complexity and variability of response to antipsychotic medications in CATIE, use of restricted formularies is not the answer...
- Insulin for the world's poorest countriesJ S Yudkin
Royal Free and University College London School of Medicine, Whittington Hospital, UK
Lancet 355:919-21. 2000..developing world where insulin availability is intermittent, and insulin may not even be included on national formularies of essential drugs...
- Status and future of vaccines for adultsJ D Grabenstein
U S Army Medical Department, School of Pharmacy, University of North Carolina, Chapel Hill 27599 7360, USA
Am J Health Syst Pharm 54:379-87. 1997..Health systems should select tetanus-diphtheria toxoids adsorbed for their formularies for immunizing adults, not monovalent tetanus toxoid...
- Diabetes in Canada: direct medical costs of major macrovascular complicationsJ A O'Brien
Caro Research, 336 Baker Avenue, Concord, MA 01742, USA
Value Health 4:258-65. 2001..To estimate direct medical costs of managing major macrovascular complications in diabetic patients...
- The formulary process from a risk management perspectiveJack H Raber
Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, University of Southern California School of Pharmacy, Los Angeles, USA
Pharmacotherapy 30:42S-47S. 2010During their evolution over the past 6 decades, hospital formularies have become more than a list of drugs that an institution keeps in stock...
- Tools for Optimizing Prescribing, Monitoring and EducationBruce L Lambert; Fiscal Year: 2010..redesign, refine, integrate, test, deploy and disseminate tools and training materials in five key areas: drug formularies, drug utilization review, lab-pharmacy linkages, N-of-1 trials and pharmacoeconomics...
- Reducing Cost-Related Medication Nonadherence in Persons with DiabetesChien Wen Tseng; Fiscal Year: 2011..The PG summarizes multiple formularies in a standard format, highlights widely covered drugs, gives retail prices from discount pharmacies, and has ..
- Epidemiologic Evaluation of State AIDS Drug Assistance Program Features in the USDavid B Hanna; Fiscal Year: 2012..state to state based on financial eligibility criteria, cost-containment measures, and inclusiveness of drug formularies with respect to antiviral therapies, opportunistic infection prophylaxis, and addiction treatment...
- Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance ProgramsBenjamin P Linas; Fiscal Year: 2011..Assistance Program resource prioritization strategies including altering eligibility rules, restructuring drug formularies, and Improving cost projections. 3...
- Differences In Incentives Between Stand Alone Medicare Drug Coverage vs MedicareKosali Ilayperuma Simon; Fiscal Year: 2010..After open enrollment, MAPDPs have stronger incentives to design formularies that optimize medical management by generously covering drugs whose use reduces hospital costs (Chandra, Gruber ..
- Exploring Therapeutic Resources in Colonial N. AmericaRenate Wilson; Fiscal Year: 2003The goal of this project is to provide wide and direct access to two rare dispensatories and formularies that illuminate the therapeutic practices and medical orientation of two physicians active in Pennsylvania during the period 1740-..
- Intelligent and Practical Geriatric Prescribing SystemsPAUL GERTMAN; Fiscal Year: 2006..GerRx will use a sophisticated, proven CDS system which references accepted medication guidelines and formularies and leverages relevant patient data for better prescribing...
- Effects of Drug Advertising on Prescription ChoiceMarta Wosinska; Fiscal Year: 2001..prescription decision-making, with special attention to the influences of direct-to-consumer advertising, formularies, and cost-sharing requirements...
- EVALUATION OF A THREE TIER COPAYBrenda Motheral; Fiscal Year: 1999..Tradition tools have included closed formularies and differential copayments for generic and brand products...
- 'Fair?' A Study of physicians' responses to restricted *Paul Adler; Fiscal Year: 2002DESCRIPTION: (Provided by the Applicant) Prior research suggests that restricted formularies--i.e...
- Distributed, Collaborative Intelligent Agents for Proactive Post-Marketing Drug SHao Ying; Fiscal Year: 2009..systems and insurers nationwide regularly make decisions regarding which drugs to include or exclude from their formularies based on evidence concerning benefits, risks, and costs of the medications...
- The Effects of Formularies and Pharmaceutical Promotion on Physicians' PrescribinGREGORY KRUSE; Fiscal Year: 2008..The primary objective is to test the impact of the following factors on drug selection: incentive-based tiered formularies, patient insurance type, pharmaceutical detailing, and pharmaceutical direct-to-consumer advertising...
- Effects of Mental Parity on High-Cost and Severely-Ill IndividualsHaiden A Huskamp; Fiscal Year: 2011..We will estimate a combination of two-part random-effects models for longitudinal data, latent class random-effects models, logistic regression models, Poisson regression models, and hazard models to address these aims. ..
- Economics of Formulary Design and Mental Health PolicyHaiden Huskamp; Fiscal Year: 2006..The second project assesses the economic incentives created by three-tier drug formularies and how these arrangements affect costs, utilization patterns, and adherence to treatment guidelines in a non-..
- Clinical Implications of Variation Among Medicare FormulariesChien Wen Tseng; Fiscal Year: 2008..However, policymakers[unreadable] are concerned that variation among the formularies of the thousands of drug plans (n = 2,743) offered in[unreadable] Medicare will make it impossible for ..
- The Eighteenth Annual Health Economics ConferenceJONATHAN KETCHAM; Fiscal Year: 2007..This year's conference will be held March 16-17 on the campus of Arizona State University in Tempe, AZ. [unreadable] [unreadable] [unreadable]..
- The Role of Customization in Psychotropic PrescribingDominic Hodgkin; Fiscal Year: 2009..However, other factors such as formularies may work against customization...
- Hospital-Physician GainsharingJONATHAN DAVID KETCHAM; Fiscal Year: 2010..The results can provide timely insights to regulators, policymakers, and managers as they consider various incentive programs to promote value through coordination. ..
- Specialty Mental Health Care--Expanding Access in an HMODominic Hodgkin; Fiscal Year: 2003..The results will inform health plan decision-makers and others as they make utilization management choices that may have a major impact on patients and enrollee populations overall. ..
- Impact of 3 Tier Drug Copays on Use and SpendingDominic Hodgkin; Fiscal Year: 2003..abstract_text> ..
- Financial Incentives and Variations in the Care of Medicare BeneficiariesBruce E Landon; Fiscal Year: 2010..Because patients will be clustered within physicians and physicians clustered within markets, we will use hierarchical analytic methods. ..
- Impact of Medicaid Policy on cardiovascular drug use and clinical outcomesMichael A Fischer; Fiscal Year: 2010....
- Can Longitudinal Population-Based Data Help to Personalize Depression Treatment?Gregory E Simon; Fiscal Year: 2010..We propose a set of targeted methodologic studies to prepare for a multi-site research consortium focused on predicting response to specific depression treatments. ..
- Modeling Adherence to Psychotherapy for DepressionGregory Simon; Fiscal Year: 2009..The proposed research is one component of an ongoing comprehensive program to understand and increase consumer demand for effective depression treatment. ..
- Research Center on Managed Care and Drug Abuse TreatmentConstance Horgan; Fiscal Year: 2008..This pilot will explore the feasibility for a large-scale study of the incremental impact of adding a substance abuse treatment parity benefit to private health insurance in California. ..
- ESCAPE Mechanistic SubstudiesRobert Califf; Fiscal Year: 2003..Catecholamines are also being collected at baseline and 3 months. In addition, the ESCAPE investigators are all ready capturing detailed demographic, clinical, and physiological information as part of the protocol for the primary study. ..
- Comparative Safety and Effectiveness of Stimulants in Medicaid Youth with ADHDAlmut G Winterstein; Fiscal Year: 2010....
- DRUG ABUSE TREATMENT UNDER MANAGED CARE--ROLE OF PPOSConstance Horgan; Fiscal Year: 2002..This study will provide systematic information on the nature and extent of these changes. ..
- Prevalence and Correlates of Psychiatric Disorders among Older AdultsScott Novak; Fiscal Year: 2008..unreadable] [unreadable] [unreadable] [unreadable]..
- Vulnerable Populations and Special Protections in ACTUsSohini Sengupta; Fiscal Year: 2007..abstract_text> ..
- COST EFFECTIVENESS OF GENETIC SCREENING FOR COLON CANCERScott Ramsey; Fiscal Year: 2002....
- A Comprehensive Database of Cost-Effectiveness AnalysesPeter Neumann; Fiscal Year: 2003..The web-based data should also understand the needs of different scientists to be understood and policymakers, and bridges to be built across disparate communities. ..
- Comparison of Methadone Units Within and Outside the CTNLORI DUCHARME; Fiscal Year: 2006..The data to be collected in this study will allow for conclusions about potential barriers to effective dissemination of evidence-based treatment for opiate dependence from CTN units to methadone programs in the "real world." ..
- Changing from Conventional to Risperidone DecanoateNancy Covell; Fiscal Year: 2005..Subjects will be interviewed with quantitative instruments at baseline and at follow-up intervals for 1 year. ..
- A Genetic Screening Policy Model for Colorectal CancerScott Ramsey; Fiscal Year: 2006..The model will incorporate QOL information from Aim 2, along with family history, clinical, and screening information from the Seattle CFR. ..
- Epidemiology and Care of Comorbid Obesity and DepressionGregory Simon; Fiscal Year: 2006..weight loss, nutrient intake, physical activity, depressive symptoms, functional impairment and disability in the two groups of women with comorbid obesity and depression randomly assigned to the two different intervention programs ..
- Industry-Sponsored Research Contracts:An Empirical StudyMichelle Mello; Fiscal Year: 2002..The data will be analyzed descriptively and with chi-squared tests and regression analysis. ..
- Economic Evaluations of Emerging Genomic Tests for Early Stage Breast CancerYA CHEN SHIH; Fiscal Year: 2008..To estimate the budgetary impact of the emerging pharmacogenomic prognostic and/or predictive tests [unreadable] [unreadable] [unreadable]..
- Pilot Trial of Peer Support for Bipolar DisorderGregory Simon; Fiscal Year: 2006..abstract_text> ..
- MD Group Characteristics and Quality of Care for CHDBruce Landon; Fiscal Year: 2003..abstract_text> ..
- Industry-Sponsored Research Contracts:..Phase IIMichelle Mello; Fiscal Year: 2004..abstract_text> ..
- Effect of a Restrictive Formulary on Low Income ChildrenJULIE URMIE; Fiscal Year: 2007..Instrumental variable analysis will be used to examine the effect of changes in antidepressant prescribing patterns caused by the restrictive formulary on health care costs. [unreadable] [unreadable] [unreadable] [unreadable]..
- POPULATION-BASED MANAGEMENT OF DEPRESSIONGregory Simon; Fiscal Year: 2003..e. 12-18 mos) Incremental cost and cost-effectiveness of each intervention program compared to care as usual. ..
- Reimbursement Policy and Cancer ChemotherapyJoseph Newhouse; Fiscal Year: 2009..Understanding its impact on chemotherapy treatment patterns has important implications not only for Medicare spending but also for the welfare of beneficiaries with cancer. ..